Therapy News and Research

RSS

Subcutaneous anchors more effective than adhesives in securing catheters

The largest study of patients with peripherally inserted central catheters (PICC) utilizing a subcutaneous anchoring securement system (SASS) ever conducted shows that using subcutaneous anchors to secure catheters is more effective than using adhesive securement devices (ASD).

25 Aug 2023

Dance helps people with Parkinson's disease negotiate their identity

A recent study by the University of Eastern Finland and Balettakademien Stockholm found that performing in a dance company and being involved in its activities play a significant role in the identity and disease-related identity negotiation in people with Parkinson's disease.

25 Aug 2023

NIH and VentureWell select winners and honorable mentions of the DEBUT Challenge

The National Institutes of Health and the higher education non-profit VentureWell have selected 10 winners and five honorable mentions of the Design by Biomedical Undergraduate Teams (DEBUT) Challenge, who are set to receive prizes totaling $145,000.

25 Aug 2023

Study shows not all adrenal carcinoma patients need mitotane after surgery

After the complete tumor resection, not all patients with an adrenocortical carcinoma require the previous standard therapy Mitotane. Professors Martin Fassnacht and Massimo Terzolo show this in a clinical trial.

25 Aug 2023

Focused update of ESC Heart Failure Guidelines integrates latest evidence-based treatments

A focused update of the European Society of Cardiology (ESC) Heart Failure Guidelines is published online today in European Heart Journal following the results of major new trials that should change the management of patients with heart failure.

25 Aug 2023

Women with endometriosis have more contact with healthcare providers in the years prior to diagnosis

Beginning as far back as ten years before even being diagnosed, women with endometriosis utilise the healthcare system more than women without this chronic illness.

25 Aug 2023

NOAH-AFNET 6 trial: Oral anticoagulation not recommended for patients with atrial high rate episodes

Blood thinners (anticoagulants) cause bleeding without preventing stroke in patients with atrial high rate episodes (AHRE), but without electrocardiogram (ECG)-diagnosed atrial fibrillation, according to late breaking research presented in a Hot Line session today at ESC Congress 2023 and simultaneously published in the New England Journal of Medicine.

25 Aug 2023

Patients with heart conditions should practice good hygiene to prevent infective endocarditis

Patients with specific cardiac conditions such as valvular heart disease and congenital abnormalities, or those requiring a pacemaker, should practice good dental and skin hygiene to help prevent rare but potentially deadly infections of the heart's inner lining and valves, according to European Society of Cardiology (ESC) Guidelines on infective endocarditis, published online today in European Heart Journal.

25 Aug 2023

Newly published ESC Guidelines provide comprehensive overview of acute coronary syndromes

The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal.

25 Aug 2023

Integrating tobacco cessation care into lung cancer screening improves quit rates

Lung cancer is the deadliest cancer in the United States, and 80% of lung cancer deaths are linked to one risk factor: smoking.

25 Aug 2023

ChatGPT 3.5 provides inappropriate cancer treatment recommendations in one-third of cases, study shows

For many patients, the internet serves as a powerful tool for self-education on medical topics. With ChatGPT now at patients' fingertips, researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, assessed how consistently the artificial intelligence chatbot provides recommendations for cancer treatment that align with National Comprehensive Cancer Network (NCCN) guidelines.

25 Aug 2023

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.

25 Aug 2023

New drug could transform treatment of brain tumors in younger people

A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people.

25 Aug 2023

New research sheds light on role of KRAS mutations in pancreatic cancer

Researchers at The University of Texas MD Anderson Cancer Center have uncovered a functional role for KRAS mutations in pancreatic cancer and rapidly translated these findings into a novel therapeutic approach combining a KRAS G12D inhibitor with immune checkpoint inhibitors for early- and late-stage KRAS G12D-mutant pancreatic cancer.

24 Aug 2023

Stem cell patch for treating macular degeneration to enter phase 2b clinical trial

A stem cell patch developed by USC researchers for patients with macular degeneration will soon be tested in a phase 2b clinical trial.

24 Aug 2023

Women with pre-eclampsia undergo accelerated aging during pregnancy

Pre-eclampsia, a life-threatening surge in blood pressure, is an enigmatic condition. Each year, it causes the deaths of more than 70,000 women worldwide. Because scientists do not know what causes it, they lack targeted strategies to treat it.

24 Aug 2023

New model predicts 10-year risk of dying from breast cancer

A team of researchers at the University of Oxford, led by the Nuffield Department of Primary Care Health Sciences, have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.

24 Aug 2023

KAUST researchers refute challenges to targeted cancer therapy

Drugs that inhibit a key protein should offer new targeted cancer therapy for leukemia and breast cancer.

24 Aug 2023

Lung cells can be trained to counteract inflammation

Inflammation is a standard part of our bodies' immune system response. But sometimes this response becomes hyperactivated in our lungs, causing inflammation to continue unchecked, which can be fatal. Many deaths from COVID-19 have been due to excessive inflammation, which results in acute lung injury.

24 Aug 2023

Urine levels of adenine found to be predictive and causative biomarker of diabetic kidney disease

Urine levels of adenine, a metabolite produced in the kidney, are predictive and a causative biomarker of looming progressive kidney failure in patients with diabetes, a finding that could lead to earlier diagnosis and intervention, researchers from The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) reported Aug. 24 in the Journal of Clinical Investigation.

24 Aug 2023

Therapy News and Research

Subcutaneous anchors more effective than adhesives in securing catheters

Dance helps people with Parkinson's disease negotiate their identity

NIH and VentureWell select winners and honorable mentions of the DEBUT Challenge

Study shows not all adrenal carcinoma patients need mitotane after surgery

Focused update of ESC Heart Failure Guidelines integrates latest evidence-based treatments

Women with endometriosis have more contact with healthcare providers in the years prior to diagnosis

NOAH-AFNET 6 trial: Oral anticoagulation not recommended for patients with atrial high rate episodes

Patients with heart conditions should practice good hygiene to prevent infective endocarditis

Newly published ESC Guidelines provide comprehensive overview of acute coronary syndromes

Integrating tobacco cessation care into lung cancer screening improves quit rates

ChatGPT 3.5 provides inappropriate cancer treatment recommendations in one-third of cases, study shows

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

New drug could transform treatment of brain tumors in younger people

New research sheds light on role of KRAS mutations in pancreatic cancer

Stem cell patch for treating macular degeneration to enter phase 2b clinical trial

Women with pre-eclampsia undergo accelerated aging during pregnancy

New model predicts 10-year risk of dying from breast cancer

KAUST researchers refute challenges to targeted cancer therapy

Lung cells can be trained to counteract inflammation

Urine levels of adenine found to be predictive and causative biomarker of diabetic kidney disease

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News